Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Finished Goods (2016 - 2018)

Historic Finished Goods for Sanofi (SNY) over the last 4 years, with Q4 2018 value amounting to $2.7 billion.

  • Sanofi's Finished Goods rose 630.19% to $2.7 billion in Q4 2018 from the same period last year, while for Dec 2018 it was $2.7 billion, marking a year-over-year increase of 630.19%. This contributed to the annual value of $2.7 billion for FY2018, which is 1082.97% up from last year.
  • Per Sanofi's latest filing, its Finished Goods stood at $2.7 billion for Q4 2018, which was up 630.19% from $2.5 billion recorded in Q4 2017.
  • In the past 5 years, Sanofi's Finished Goods ranged from a high of $2.7 billion in Q4 2018 and a low of $2.3 billion during Q4 2015
  • Moreover, its 4-year median value for Finished Goods was $2.4 billion (2017), whereas its average is $2.5 billion.
  • Its Finished Goods has fluctuated over the past 5 years, first surged by 187.66% in 2016, then soared by 1001.53% in 2017.
  • Over the past 4 years, Sanofi's Finished Goods (Quarter) stood at $2.3 billion in 2015, then increased by 1.88% to $2.3 billion in 2016, then increased by 10.02% to $2.5 billion in 2017, then rose by 6.3% to $2.7 billion in 2018.
  • Its last three reported values are $2.7 billion in Q4 2018, $2.5 billion for Q4 2017, and $2.3 billion during Q4 2016.